Tropisetron

From WikiMD's WELLNESSPEDIA

Medication used to treat nausea and vomiting

Tropisetron


Trade names Navoban


Chemical nomenclature
IUPAC name (3aS)-2,3,3a,4,5,6-Hexahydro-1H-indole-3-carboxylic acid [1-methyl-1H-indol-3-yl]-methyl ester



Routes Oral, Intravenous







Identifiers
CAS Number 89565-68-4
PubChem 5583
DrugBank DB00757
ChemSpider 5383
UNII 1C83566V6M
KEGG D00372
ChEMBL 1201310
Chemical data


Chemical formula C17H20N2O2


SMILES CC1(C2=CC=CC=C2NC1)C(=O)OCC3=CN(C)C4=CC=CC=C34




Tropisetron is a pharmaceutical drug used primarily as an antiemetic to treat nausea and vomiting caused by chemotherapy and radiotherapy. It is also used to prevent postoperative nausea and vomiting. Tropisetron is a selective 5-HT3 receptor antagonist, which means it works by blocking the action of serotonin at the 5-HT3 receptors.

Medical uses[edit]

Tropisetron is indicated for the prevention and treatment of nausea and vomiting induced by chemotherapy and radiotherapy. It is also used to prevent postoperative nausea and vomiting. The drug is administered either orally or intravenously.

Mechanism of action[edit]

Tropisetron works by selectively blocking the 5-HT3 receptors in the central nervous system and the gastrointestinal tract. By inhibiting the action of serotonin at these receptors, it prevents the activation of the vomiting reflex.

Pharmacokinetics[edit]

Tropisetron is well absorbed after oral administration. It undergoes hepatic metabolism and is excreted primarily via the kidneys. The elimination half-life of tropisetron is approximately 8 hours.

Side effects[edit]

Common side effects of tropisetron include headache, constipation, and dizziness. Rare but serious side effects may include allergic reactions and cardiac arrhythmias.

Contraindications[edit]

Tropisetron is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with hepatic impairment or renal impairment.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.